TGFB2 and central nervous system cancer: Friese et al. [24] demonstrated that combined TGF-β1and TGF-β2 knock down in human LNT-229 glioma cells results in aloss of tumorigenicity when xenografted into CD1 nude mice, and natural killercells isolated from these animals show an activated phenotype.